On March 5th, VIMEA is hosting renowned cannabis researcher Dr. Michelle Sexton for a special two hour examination of cannabis as herbal medicine.
Get you ticket now to reserve your seat! http://cannabismedicine.eventbrite.com/
Dr. Michelle Sexton will examine the plant components, the historical record, it's classification as an herb, how it works as medicine via the endocannabinoid and other systems, and how to use it wisely and in combination with other therapies. She will discuss some common conditions that patients find it useful for such as Multiple Sclerosis, Parkinson’s, epilepsy, chronic pain, anxiety and depression.
The intended audience for this presentation are health care providers, herbalists, clinicians, patients and other individuals wanting a better understanding of the scientific research into cannabis as a medical herb.
$10.00 per person to attend. All proceeds go to charity. No one turned away for lack of funds so long as seats remain. Online sales end on March 5th at 3pm or when the seats are sold out.
The location is on Vashon Island right next to the North End ferry dock. If coming from Seattle, you save some money and can park in West Seattle and walk on the Vashon-Fauntleroy ferry. The Grange Hall is located in the North End ferry parking lot on Vashon. Very easy. The 6:00pm and 6:30pm ferries from Fauntleroy West Seattle will both make the 20 minute trip in time for the 7pm event. If you take the 6:30pm ferry make sure to buy your ticket in advance and hustle up to the parking lot because you will be cutting it close.
About Dr. Michelle Sexton
Dr. Sexton is Executive Medical Research Director at The Center for the Study of Cannabis and Social Policy. She is a Naturopathic Doctor, herbalist and formerly a midwife currently in private practice in San Diego. She began her formal study of phytochemicals with a degree in horticulture, and has specialized in the phytochemical analysis of botanical medicines and their application to neuroinflammation, specifically the role of the endogenous cannabinoid signaling system. She completed a three-year NIH-funded postdoctoral fellowship at the University of Washington in the Departments of Pharmacology and Psychiatry and Behavioral Sciences. She conducted a clinical study examining the effects of Cannabis use on some defined immune parameters in patients with Multiple Sclerosis. She has published original research in peer-reviewed journals and presented her research internationally She owned and operated Phytalytics LLC, a Cannabis analysis laboratory, and served as an editor/advisor on the American Herbal Pharmacopoeia Cannabis monograph. She has been a consultant to the Washington State liquor control Board on the implementation of I-502. She is a member of the International Cannabinoid Research Society, the International Association for Cannabinoid Medicines, and the Society of Cannabis Clinicians,. She provides continuing education to advanced practice nurses, physicians’ assistants and naturopathic doctors on clinical Cannabis use in Washington State. Dr. Sexton serves on the Board of Directors for Americans for Safe Access Foundation and served as co-chair of the Scientific Advisory Committee. See Dr. Sexton’s publications.